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Abstract Working memory deficits are found in different
psychiatric populations and are most pronounced in
schizophrenia. There is preliminary evidence from phar-
macological studies that the verbal and visuospatial sub-
components of working memory are subject to differential
neurotransmitter modulation. Here, we investigated the
impact of well-known polymorphisms of the dopamine
transporter gene (SLC6A3, DAT) and the catechol-O-
methyl-transferase gene (COMT) as well as the serotonin
transporter gene (SLC6A4, 5-HTT) on these specific
working memory subcomponents in a mixed sample of
patients and healthy individuals. Twenty healthy subjects
and 80 patients diagnosed with schizophrenia, bipolar I
disorder, or obsessive-compulsive disorder underwent
genotyping for the DAT variable number of tandem repeats
(VNTR), the COMT val/met-, and the 5-HTT promoter
length polymorphism (5-HTTLPR) and neuropsychological
testing using a battery of well-characterized, brain circuit–
specific working memory tasks. DAT genotype revealed a
significant and selective effect on visuospatial working
memory, while there was no effect on verbal working
memory functioning. 5-HTT genotype, by contrast, exerted
a significant and selective effect on verbal working mem-
ory task performance. COMT genotype did not show any
influence on either working memory domain. The results of
the present study provide evidence for a differential impact
of genetic polymorphisms of the dopaminergic and sero-
tonergic systems on verbal and visuospatial working
memory functioning. Together with prior evidence sug-
gesting the existence of subgroups of schizophrenia
patients exhibiting isolated deficits in only one working
memory domain, this finding further supports the idea of
endophenotypically and pathophysiologically distinct sub-
groups of schizophrenia with implications for personalized
therapeutic approaches.
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Introduction
Working memory (WM) deficits have been described in
different psychiatric populations and are most prominently
found in schizophrenia [21]. Therefore, WM dysfunction is
supposed to represent a promising endophenotype for
psychotic disorders including schizophrenia and bipolar
disorder [41]. According to the endophenotype concept
[24], neurocognitive functions are thought to mediate
between the genetic basis of psychiatric disorders and their
complex and often phase-dependent clinical phenotype.
Endophenotypes are assumed to be influenced more
directly and (being less complex phenotypes) by a smaller
number of genes compared to the disease phenotypes. The
identification of genes influencing WM functioning may
prove helpful to elucidate possibly shared genetic and
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pathophysiological processes with an impact on both
endophenotype and disease. In this context, genes that
directly affect the neurotransmitter systems that are pre-
sumably involved in the pathophysiology of psychiatric
disorders are especially interesting. Knowledge about their
pathophysiological effects could help to generate new
therapeutic approaches for treating both cognitive dys-
function and clinical symptomatology.
As a basic cognitive function, WM comprises the
short-term storage (maintenance) and manipulation of a
limited amount of information. It is assumed to consist of
different specialized subsystems including the phonologi-
cal loop for the maintenance of verbal information and the
visuospatial sketchpad for the maintenance of spatial
information [5]. Previous functional MRI studies have
identified distinct neural networks underlying specific
verbal and visuospatial WM functions in healthy indi-
viduals [26, 27, 30, 32, 33, 44] and psychiatric popula-
tions [31, 37–39]. Together with complementary lesion
studies [29], these data allowed to establish clear brain-
behavior relationships between specific brain circuits and
the verbal and visuospatial subcomponent of human WM.
Behavioral deficits in patient populations can thus be
attributed to specific disturbances of the underlying neu-
rofunctional systems [28, 34, 71–73]. Interestingly, a
recent study provided evidence for the existence of sub-
groups of patients with schizophrenia who exhibit isolated
deficits in only one domain of WM [72], suggesting a
selective disturbance of the neural networks underlying
either verbal or visuospatial WM functioning.
In accordance with the neuroanatomical dissociation of
the verbal and visuospatial WM subcomponent, there is
some evidence that these WM domains are subject to dif-
ferential neurotransmitter modulation. As pharmacological
studies in animals have of course focused on spatial WM
(for review, see [18]), particularly for this domain, an
association between dopamine levels and performance has
been established. Spatial WM performance is assumed to
depend on an optimal level of dopaminergic signaling in
terms of an inverted U-shaped curve. Most pharmacologi-
cal studies in humans also investigated the effects of
altered dopamine levels on the visuospatial component of
WM (for reviews, see [6, 20]), while data are much scarcer
for the verbal domain with negative results, for instance,
for the n-back WM task [43]. Other neurotransmitter sys-
tems are also involved in the modulation of cognitive
processes. Regarding serotonin, there is at least some evi-
dence for a selective modulatory effect on verbal memory
functions. One study investigating healthy adults found a
worsening of verbal (digits backward) and affective (pic-
tures of facial affect) WM performance following trypto-
phan loading (leading to increased cortical serotonin
levels), while this condition had no effect on spatial
memory span [49]. In another study, tryptophan depletion
(leading to reduced serotonin synthesis) resulted in
impaired delayed word recall while leaving spatial WM
unaffected. Tyrosine and phenylalanine depletion (pre-
dominantly leading to dopaminergic changes), by contrast,
resulted in a worse performance in spatial WM but not
delayed word recall [35]. The evidence outlined above thus
endorses the notion that serotonergic modulation primarily
affects verbal but not visuospatial cognitive processes,
whereas the opposite could be true for dopaminergic
neurotransmission.
Dopamine levels are substantially regulated by its re-
uptake via the dopamine transporter (DAT) and by enzy-
matic degradation by catechol-O-methyl-transferase
(COMT) or monoamine oxidase A (MAOA). The activity
of these clearing processes varies by the existence of dif-
ferent polymorphisms in the respective genes (COMT,
MAOA). The COMT valine/methionine-encoding poly-
morphism (Val158Met) is characterized by a decreased
enzyme activity for the methionine variant at body tem-
perature [46] and consequently higher synaptic dopamine
levels. With regard to the DAT gene (DAT), there is a
variable number of tandem repeats (VNTR) polymorphism
leading to altered gene expression. Results concerning the
functional consequences of the DAT VNTR polymorphism
(i.e., DAT availability as measured by SPECT) have,
however, been inconsistent [68].
Associations of these polymorphisms with cognitive
measures have been reported. There is some evidence for
better performance of individuals homozygous for the
methionine-encoding variant of COMT compared to the
val/val genotype especially in the Wisconsin card sorting
test (WCST) [16, 19] and also in n-back tasks [22]. How-
ever, a recent meta-analysis [7] did not confirm these
effects. Another study provides evidence for better per-
formance of healthy DAT 10/10 individuals in smooth
pursuit eye movement, a construct similar to visuospatial
working memory [69].
Serotonin levels are in part regulated by the serotonin
transporter (5-HTT). A polymorphism in the regulatory
region of the respective gene (5-HTT), the 5-HTT linked
polymorphic region (5-HTTLPR), leads to altered 5-HTT
expression in vitro. Higher expression was associated with
the long (L) allele as compared to the short (S) allele [36].
A positron emission tomography study found 5-HTT
availability in the PFC and the parietal cortex to be asso-
ciated with the performance in several verbal memory tasks
including digit span forward and backward [50]. However,
to our knowledge, there are no publications that reported
significant associations between 5-HTTLPR genotype and
specific WM measures to date.
The aim of the present study was to investigate the
impact of genetic polymorphisms of the dopaminergic and
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serotonergic system (i.e., DAT, COMT, and 5-HTT) on
different verbal and visuospatial WM maintenance tasks in
a mixed sample of healthy probands and patients with
schizophrenia, bipolar disorder, and obsessive-compulsive
disorder. According to the evidence outlined above, our
hypothesis was that the DAT and COMT polymorphism
would impact on visuospatial but not verbal WM, whereas
the 5-HTT polymorphism should vice versa influence
verbal but not visuospatial WM functioning.
Methods
Subjects
A total of 100 subjects were included in this study com-
prising patients with schizophrenia (n = 32), bipolar I
disorder (n = 22), obsessive-compulsive disorder
(n = 26), and healthy individuals (n = 20). Selection cri-
teria for patients were diagnosis of schizophrenia, bipolar
disorder, or obsessive-compulsive disorder, according to
ICD-10 criteria, and age range from 18 to 65 years.
Exclusion criteria were acute suicidality, involuntary
treatment, current substance abuse, history of brain trauma,
diseases with alterations in cerebral metabolism, uncor-
rected visual or auditory disability, and mental retardation.
Exclusion criteria for healthy control subjects were the
same as above plus the presence of any past or present
psychiatric disorder. Diagnoses were established through
clinical interviews by two experienced psychiatrists using
symptom checklists according to ICD-10 criteria. At the
time of study participation, most patients received a stable
medication including typical and atypical antipsychotics,
antidepressants, mood stabilizers, and low-dose benzodi-
azepines depending on the disorder. For further sample
characteristics, see Table 1. All subjects gave written
informed consent before participation. The study was
approved by the local ethics committee.
Experimental design
Testing was conducted in an experimental neuropsycho-
logical laboratory under standardized conditions using a
modified Sternberg paradigm (delayed match-to-sample
task) [62]. The behavioral experiment consisted of four
tasks testing verbal and visuospatial WM, each under sin-
gle-task conditions (i.e., active rehearsal of the sample
items) as well as under dual-task conditions (i.e., articu-
latory or visuospatial suppression). These different task
conditions were conducted in a blocked manner, and each
task was repeated 50 times with a short pause after 25
trials. The order of tasks was counterbalanced across sub-
jects within each diagnostic group.
Stimulus presentation was identical for each of the four
task conditions. A 5 9 5 matrix appeared on the monitor
for 2 s with four squares of the matrix randomly filled by
also randomly chosen, phonologically similar letters. In the
3.2-s delay period, the empty matrix was visible together
with a little star moving across the screen. Simultaneously,
rhythmic 4-kHz tones were presented throughout the delay
period with a repetition frequency of 3.3 Hz to set the pace
of the rehearsal or counting. During this interval, subjects
had to keep the letters or the spatial positions in mind using
the specific strategies described below. In the response
phase, a single letter was presented in the matrix for 2 s.
Subjects had to decide whether the probe letter (verbal WM
tasks) or its position (visuospatial WM tasks) matched one
of the four target letters or positions, respectively, pre-
sented at the beginning. Together with the 2-s intertrial
interval, the total length of a single trial was 9.2 s resulting
in a task duration of about 8 min for each of the four tasks.
In the ‘verbal rehearsal task’, subjects were instructed to
vocalize the four sample letters internally one time in the
presentation period and then to rehearse them throughout
the delay period. In the ‘non-articulatory phonological
maintenance task’, subjects were instructed to vocalize the
four sample letters one time but then to continuously count
from one to four during the delay period. This articulatory
suppression task has been proven to selectively interfere
with verbal WM [4, 33]. In the ‘visuospatial rehearsal
task’, subjects were instructed to repetitively perform overt
shifts of attention to the four spatial positions, a strategy
termed ‘visuospatial rehearsal mechanism’ by some
authors [3]. In the ‘visuospatial pattern maintenance task’,
subjects had to remember the spatial pattern built by the
four sample positions while performing a visuospatial
suppression task by following the moving star with their
eyes. This procedure had been proven to selectively
interfere with visuospatial WM [4, 33].
Genotyping
Standard PCR and genotyping were performed essentially
as described earlier by our group. For DAT-specific PCR
conditions, see [58]; for 5-HTTLPR, see [59]; for COMT,
see [54].
Statistical analysis
All statistical analyses were performed using PASW Sta-
tistics, version 18.0.0. According to our hypothesis
regarding a differential impact of dopaminergic and sero-
tonergic neurotransmission on verbal and visuospatial WM
functions, we first performed analyses of variance (ANO-
VAs) for each of the three genes (DAT, COMT, and 5-HTT)
with genotype and diagnosis as factors. Dependent
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variables were visuospatial WM task performance for DAT
and COMT and verbal WM task performance for 5-HTT.
Given the a priori hypotheses we had for each gene,
adjustment for multiple comparisons was not required for
these analyses. Subsequently, multivariate analyses of
variance (MANOVAs) with genotype and diagnosis as
factors were performed to confirm the selectivity of
genotype effects on the different WM domains. When
significant main effects were present, Bonferroni-corrected
post hoc comparisons were made.
With regard to the genotypes, the following groups were
analyzed. For DAT, 9-repeat carriers were grouped together
as it has been established by previous studies [11, 55]
because of the relatively small number of 9-repeat homo-
zygote subjects. Group comparisons were thus made for
10-repeat homozygotes versus 9-repeat carriers. For
COMT, there are reports on a dose-dependent effect of the
met-allele on cognitive performance [19], and thus all
genotypes (val/val, val/met, met/met) were considered in
the primary analysis. However, as there is also evidence for
a worse performance of val-homozygotes compared to
met-carriers [19] and a better performance of met-homo-
zygotes compared to val-carriers [16], additional analyses
were conducted using these groupings. For 5-HTT, there is
evidence for higher expression levels and higher 5-HT
uptake in L-homozygotes as compared to S-carriers. S/S
and S/L genotypes in turn do not show large differences
[25, 70]. Thus, group comparisons were made for L-
homozygotes versus S-carriers. As both the DAT and
COMT polymorphisms affect dopamine levels, a possible
epistatic effect in terms of a DAT 9 COMT interaction was
analyzed by another MANOVA now considering DAT,
COMT, and diagnosis as factors.
Unlike in prior publications, we did not consider age and
years of education as covariates. In the subgroups built
according to the genetic polymorphisms, there were no
significant differences with regard to age. As to education,
there is good evidence that WM more likely exerts an
effect on the individual’s educational level than vice versa
as WM functioning has been proven to be a strong pre-
dictor of subsequent educational success [1, 2]. To further
support this assumption, we conducted a mediation anal-
ysis according to Baron and Kenny [9] performing the
following linear regression analyses:
1. Predictor: genotype; criterion: years of education
2. Predictor: genotype; criterion: WM performance (puta-
tive mediator)
Table 1 Sample characteristics
Healthy (n = 20) Schizophrenia (n = 32) Bipolar disorder (n = 22) OCD (n = 26)
Demographic factors
Age 34.9 (12.7) 36.3 (10.2) 43.8 (12.4) 35.5 (8.8)
Years of education 14.9 (2.66) 13.5 (3.2) 14.6 (3.1) 13.7 (2.2)
Gender (m; f) 6; 14 17; 15 11; 11 11; 15
Genotype
DAT (10/10; 9-carriers) 9; 11 21; 11 14; 8 14; 12
5-HTT (L/L; other) 9; 11 11; 20 (missing: 1) 7; 15 10; 16
COMT (met/met; val/met; val/val) 4; 9; 6 (missing: 1) 6; 21; 4 (missing: 1) 6; 7; 9 6; 10; 10
Symptom scores
CGI 3.94 (0.93) 3.52 (1.63) 3.85 (1.08)
MADRS 11.78 (7.54) 6.77 (7.33) 11.2 (7.42)
PANSS positive 13.83 (4.65) 8.0 (1.45) n/a
PANSS negative 12.9 (5.05) 9.6 (4.96) n/a
YMRS n/a 3.38 (2.96) n/a
Y-BOCS n/a n/a 20.77 (7.69)
WM performance (accuracy in %)
Verbal rehearsal 94.4 (3.5) 82.9 (12.1) 89.1 (6.6) 91.4 (7.1)
Non-articulatory phonological maintenance 87.4 (5.6) 79.6 (10.8) 81.3 (9.9) 79.9 (8.2)
Visuospatial rehearsal 93.6 (7.0) 79.7 (15.1) 85.9 (11.4) 88.0 (11.6)
Visuospatial pattern maintenance 89.1 (8.8) 75.4 (13.8) 82.9 (9.8) 80.7 (13.1)
Given are the means (standard deviations) of demographic variables, genotype frequencies, and the psychopathology scores of the diagnostic
groups
CGI Clinical Global Impression, MADRS Montgomery Asberg Depression Rating Scale, PANSS Positive and Negative Syndrome Scale, YMRS
Young Mania Rating Scale, Y-BOCS Yale-Brown Obsessive Compulsive Scale
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3. Predictors: WM performance and genotype; criterion:
years of education
Mediation can be assumed if there is a significant effect
in 1 and 2, a significant effect for the putative mediator in
3, and a reduced effect for genotype (independent variable)
in 3 as compared to 1.
Results
The allelic distribution of all three genes was in Hardy-
Weinberg equilibrium (DAT: df = 1, v2 = 1.73,
p = 0.189; COMT: df = 1, v2 = 0.126, p = 0.722; 5-
HTT: df = 1, v2 = 0.062, p = 0.803). Genotype groups
did not differ significantly with regard to age, gender, and
diagnosis frequencies (see Table 2). As to years of edu-
cation, there was a statistically significant difference for
DAT genotype and a statistical trend for 5-HTT genotype.
According to our hypothesis that WM performance
would impact on the participants’ educational level rather
than vice versa, a mediation analysis according to Baron
and Kenny [9] was conducted to confirm the expected
mediating effect of WM performance on the dependent
variable ‘years of education’. According to this approach, a
series of linear regression analyses revealed:
1. A significant effect of genotype on years of education
(DAT: p = 0.01; 5-HTT: p = 0.053)
2. Significant effects of DAT on visuospatial WM
performance (visuospatial rehearsal: p = 0.02) and
of 5-HTT on verbal WM performance (verbal
rehearsal: p = 0.024)
3. Significant effects of verbal (verbal rehearsal:
p \ 0.0005) and visuospatial WM performance (vis-
uospatial rehearsal: p = 0.006) on years of education
when controlling for genotype; a reduced significance
of the effect of genotype on years of education (DAT:
p = 0.044; 5-HTT: p = 0.217) when controlling for
the respective WM task
Thus, a mediating effect of WM performance on years of
education can be assumed. Consequently, years of education
was not used as a covariate in the further analyses.
According to our a priori hypotheses, we then conducted
analyses of variance (factors: diagnosis and genetic poly-
morphism) to determine the effects of the above-described
DAT and COMT polymorphisms on visuospatial WM
performance and of the 5-HTT polymorphism on verbal
WM performance. In the following, the results are pre-
sented for each gene separately (cf. Table 2).
DAT: There was a significant effect of DAT genotype
on ‘visuospatial rehearsal’ (F (1, 92) = 3.97, p = 0.049)
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performance compared to the 9-repeat carriers. No signif-
icant effect was observed regarding ‘visuospatial pattern
maintenance’.
As for diagnosis, there was a significant effect for both
visuospatial WM tasks (visuospatial rehearsal: F (3,
92) = 5.3, p = 0.002; visuospatial pattern maintenance:
F (3, 92) = 6.08, p = 0.001). Bonferroni-corrected pair-
wise comparisons revealed a significantly worse perfor-
mance of the schizophrenia group when compared to the
healthy subjects for both visuospatial WM tasks. There was
no significant DAT-diagnosis interaction effect.
COMT: No significant effects of COMT genotype (val/
val vs. val/met vs. met/met) on visuospatial WM perfor-
mance were observed. Also when using other contrasts
(i.e., val-homozygotes vs. met-homozygotes, val-carriers
vs. met-homozygotes, and met-carriers vs. val-homozy-
gotes), there was no significant effect of COMT genotype.
A significant effect of diagnosis was observed for both
visuospatial WM tasks (visuospatial rehearsal: F (3,
86) = 3.23, p = 0.026; visuospatial pattern maintenance:
F (3, 86) = 3.46, p = 0.02) with the schizophrenia group
performing worse than healthy subjects in both tasks. There
was no significant COMT-diagnosis interaction effect.
5-HTT: There was a significant effect of 5-HTT geno-
type on ‘non-articulatory phonological maintenance’ (F (1,
91) = 3.74, p = 0.001) and a statistical trend for the
‘verbal rehearsal’ task (F (1, 91) = 12.13, p = 0.056). L-
homozygote subjects performed better compared to the
S-allele carriers in both tasks.
A significant effect of diagnosis was present for both
verbal WM tasks (non-articulatory phonological mainte-
nance: F (3, 91) = 3.11, p = 0.03; verbal rehearsal: F (3,
91) = 7.84, p \ 0.0005) with the schizophrenia group per-
forming worse than healthy subjects in both tasks and worse
than the OCD group in the verbal rehearsal task. There was
no significant 5-HTT-diagnosis interaction effect.
To further test the selectivity of genotype effects as
revealed by these hypothesis-driven analyses, we then
conducted multivariate analyses of variance (MANOVAs;
factors genotype and diagnosis) for each gene now
including all applied WM tasks. In the following, we report
the results of these additional multivariate analyses. The p-
values of the post hoc multiple comparisons were Bon-
ferroni-adjusted. For DAT, there was a significant main
effect of diagnosis (p = 0.001) but not of DAT genotype
and DAT-diagnosis interaction. In the univariate tests, there
were no significant effects of DAT genotype on verbal WM
performance. For COMT, there was a significant main
effect of diagnosis (p = 0.003) but not of COMT genotype
and COMT-diagnosis interaction. In the univariate tests,
there was no significant effect of COMT genotype on
verbal WM performance. For 5-HTT, there were significant
effects of diagnosis (p = 0.001) and 5-HTT genotype
(p = 0.005) but not of 5-HTT-diagnosis interaction. In the
univariate tests, there were no significant effects of 5-HTT
genotype on visuospatial WM performance.
Regarding a possible epistasis of the DAT and COMT
genes, no significant DAT-COMT interaction effect was
observed.
Discussion
In this study, we investigated the impact of DAT, COMT, and
5-HTT polymorphisms on verbal and visuospatial WM
functioning. Our main findings are a significant and selective
influence of the DAT VNTR on a visuospatial WM mainte-
nance task and a significant and selective influence of the 5-
HTTLPR on verbal WM functioning. In contrast, no signif-
icant effect on WM performance was found for the COMT
Val158Met. This finding of a differential influence of func-
tional genetic polymorphisms of the dopaminergic and
serotonergic system on verbal versus visuospatial WM
subcomponents gives support to our primary hypothesis that
these WM functions do not only rely on distinct neuroana-
tomical networks but are also subject to differential genetic
and neurotransmitter modulation.
Effects of DAT on working memory
Most prior studies investigating the impact of the DAT
polymorphism on WM-related measures failed to find
significant effects. Negative results have been reported for
verbal fluency [55], WM n-back tasks [11, 12, 17], and
WCST [17, 64]. In contrast, a significantly better perfor-
mance of healthy DAT 10-repeat homozygotes as com-
pared to 9-repeat carriers (and vice versa for schizophrenia
patients) was found for smooth pursuit eye movement
(SPEM) [69]. SPEM is a construct similar to visuospatial
WM, and fMRI studies revealed overlapping brain acti-
vations during the performance of SPEM and the specific
visuospatial WM task used here [10, 33]. Thus, the finding
of DAT genotype affecting the performance in both tasks
could reflect this functional and anatomical overlap. Fur-
ther evidence for an effect of DAT genotype on spatial WM
comes from an animal study, which reported Y Maze
Spontaneous Alternation, a measure of spatial WM in
rodents, to be impaired in DAT knockout mice as compared
to the wild type [48]. The findings of the present study and
the earlier literature outlined above thus support our
hypothesis of an influence of DAT genotype (and thus
dopamine) particularly on the visuospatial WM domain.
However, interpretation of these data is restricted by dif-
ferent directions of the DAT effect. While we found a better
visuospatial WM performance in 9-repeat carriers as
compared to 10-repeat homozygotes in our mixed sample,
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Wonodi [69] reported the opposite effect with a better
performance of the healthy 10-homozygotes. These con-
flicting results may be also due to the divergent findings
regarding the effects of the DAT polymorphism on protein
expression and consequent effects on baseline dopamine
levels. While some authors reported higher DAT binding in
9-repeat carriers, others found the opposite (for review, see
[68]). The effects of DAT genotype on cognition are hard to
interpret as long as the functional effects of this polymor-
phism are not sufficiently understood. Although there is
limited but consistent evidence for an influence of the DAT
polymorphism on visuospatial WM and related brain
functions, possible mechanisms at the level of dopami-
nergic neurotransmission remain to be elucidated.
Effects of COMT on working memory
Although a recent meta-analysis [7] did not find any sig-
nificant effects of the COMT Val158Met-encoding poly-
morphism on various cognitive measures, some previous
studies found such effects on n-back tasks and WCST [19,
22]. In our current study, we did not observe a significant
effect of COMT genotype on either verbal or visuospatial
WM maintenance tasks. A possible explanation for this
divergence is the type of task used in the different studies
as the construct of WM comprises a variety of test para-
digms that considerably differ with respect to their cogni-
tive demands (maintenance, manipulation, or the additional
requirement of executive functions). Thus, the different
WM tasks may represent at least in part different neuro-
cognitive functions. Consistent with this, Bruder [16]
investigated the effect of COMT genotype on various WM
measures in healthy adults and found genotype differences
only for the WCST and the letter number sequencing test
(LNS) but not for a spatial delayed response task, n-back
task, and word serial position test. The authors argued that
COMT could selectively affect the higher-order processing
components (like executive functions and mental manipu-
lation) but not mere maintenance and updating processes.
This would be in line with the negative finding for COMT
in our study as we also applied rather simple WM main-
tenance tasks.
Differential effects of DAT and COMT on working
memory
The finding of a significant influence of the DAT but not the
COMT polymorphism on visuospatial WM is to some
extent counterintuitive. It is widely accepted that WM
functioning is particularly related to the prefrontal cortex
(PFC) (e.g., [23]). Given the relative minor role of DAT for
dopamine clearance in this area as compared to striatum
[60, 61, 67], one would rather expect the COMT genotype
to impact on WM functioning. However, the neural net-
works activated during WM task performance are not
restricted to the PFC but involve other brain areas in which
the relative importance of DAT may be different from PFC.
(As Patricia Goldman-Rakic said, ‘understanding the pre-
frontal component is but one part of the grand design’ [23]).
For the specific visuospatial WM task used here, functional
activations have been shown in a bilateral prefrontoparietal
network including, for instance, the cortices along posterior
parts of the superior frontal sulcus and along the intrapari-
etal sulcus [33]. Interestingly, there is evidence for the
presence of DAT also apart from brain regions with estab-
lished dopaminergic pathways. Lewis [47] found that DAT-
immunoreactive axons are present throughout the cortex in
macaques with a particularly high density of DAT immu-
noreactivity found in the posterior parietal cortex, sug-
gesting a direct dopaminergic influence in this area. For
humans, there is at least indirect evidence for an influence
of DAT in the (posterior) parietal cortex. Two recent fMRI
studies found that differences in both DAT availability [65]
and DAT genotype [63] impact on brain activations in
parietal regions. Thus, there is evidence for a relevant
influence of DAT (be it of direct or indirect nature) on the
human parietal cortex, which is activated during visuospa-
tial WM task performance. This provides a possible
explanation for our finding of a significant influence of the
DAT genotype on visuospatial WM functioning.
Effects of 5-HTT on working memory
To our knowledge, this is the first report of a significant effect
of the 5-HTTLPR genotype on specific verbal WM functions.
Studies of an association of 5-HTTLPR with performance in
the WCST yielded conflicting results with sometimes the
S-allele [13] and sometimes L-homozygosity [14] being
associated with better executive performance. Other recently
published studies did not detect any associations between the
5-HTT polymorphism and WM measures, specifically the
Count Span task [8] and a WM summary score comprising a
visuospatial WM task and LNS [45].
Our finding of a better performance of L-homozygote
individuals in specific verbal WM tasks thus seems to be
inconsistent with these prior results. This inconsistency
may, however, be explained by the type of WM measure
used in the different studies. While we applied simple WM
maintenance tasks, the above-mentioned studies used more
complex paradigms (including more than only WM
demands) or composite scores (comprising different task
demands and WM domains). However, the more complex
the paradigm and the more cognitive processes are
involved, the more likely various neurotransmitter systems
will play a role in task performance. A lack of process
specificity of the applied tasks will thus dilute existing
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genetic effects and lead to a decreased sensitivity for their
detection. Future studies should therefore apply cognitive
processes that are deconstructed as far as possible to the
level of ‘cognitive atoms’ as the use of such simple and
purer cognitive processes seems to be a more promising
approach for the investigation of genetic effects on
cognition.
Limitations
The findings of our study are of course limited by the
relatively small sample size and the heterogeneity of the
study sample that comprised healthy subjects as well as
patients with schizophrenia, bipolar I disorder, and obses-
sive-compulsive disorder. Replication is needed using lar-
ger and more homogeneous samples. This will also help to
control for putative effects of psychopharmacological
treatment on WM performance which we cannot exclude in
our mixed and medicated patient sample. Publications on
this issue, however, yielded contradictory results concern-
ing whether and how antipsychotics [52, 56] and antide-
pressants [40, 57, 66] affect WM functioning with some
evidence that putative effects depend more on individual
differences in the receptor profiles of the substances (e.g.,
anticholinergic properties) than on mere substance class or
dose effects [51, 53]. To solve the issue of possible med-
ication effects in patient samples, studies including drug-
naı¨ve patients or prespecified pharmacological regimens
are needed.
A further limitation is the use of the biallelic 5-HTTLPR
polymorphism that only considered the S- and L-allele.
More recent data suggest this polymorphism to be triallelic,
and only the LA-allele was associated with increased 5-
HTT mRNA levels in contrast to the LG-allele, which was
functionally similar to the S-allele [42]. However, other
recently published studies also used the biallelic 5-HTT
polymorphism and reported significant effects on both
cognitive measures [13, 14] and 5-HTT mRNA levels and
activity [70]. Furthermore, a recent SPECT study investi-
gating the effects of the 5-HTTLPR polymorphism on
resting state perfusion in acutely depressed subjects
revealed very similar findings comparing the biallelic and
triallelic approach [15], which suggests that the conse-
quences of analyzing the triallelic instead of the biallelic
polymorphism might be small.
Conclusions
Summarized, our study provides evidence for an indeed
differential influence of genetic polymorphisms of the
serotonergic and dopaminergic system on the verbal and
visuospatial subcomponent of WM. Together with prior
evidence suggesting the existence of subgroups of
schizophrenia patients with isolated deficits in only one
working memory domain, this finding further supports the
idea of endophenotypically and pathophysiologically dis-
tinct subgroups of schizophrenia with implications for
possible differential and personalized therapeutic approa-
ches. Methodologically, the use of preferably simple and
pure cognitive processes seems to be a promising approach
for the investigation of genetic associations with cognitive
parameters and is recommended for future studies.
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